Zydus Lifesciences Ltd. (ZYDUSLIFE): Zydus Lifesciences Share Price rises 2.90% to Rs 1,153.55 in market update

Zydus Lifesciences Share Price is trading at Rs 1,153.55, up 2.90% from the previous close of Rs 1,121.00, with a market capitalisation of Rs 1,11,820.18 crore. The move places Zydus Lifesciences Ltd. among the notable Stocks in News in the Indian Stock Market today. The latest Univest data confirms the price rise, but it does not establish a company-specific catalyst, so the focus stays on verified price action and financial context. For investors tracking Zydus Lifesciences Share Price Today, the key questions are whether the current valuation remains reasonable versus Healthcare peers and how the stock sits against sector benchmarks.

On the session so far, the stock opened at Rs 1,110.55, moved to a low of Rs 1,110.55 and touched a high of Rs 1,162.50. That range shows active buying interest in Zydus Lifesciences Share Price Today, even as the company-specific reason for the rise is not confirmed by the latest Univest figures. In this Zydus Lifesciences Stock News update, the cleaner way to read the move is through price action, valuation and sector positioning rather than speculation. Univest readers can use the company page to follow the counter as part of broader Market News and Share Market Today tracking.

Zydus Lifesciences Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,153.55
Previous Close	Rs 1,121
Today's Move	Rs 32.55 (+2.9%)
Open	Rs 1,110.55
High	Rs 1,162.5
Low	Rs 1,110.55
Turnover	Rs 7.39 crore
Market Capitalisation	Rs 1,11,820.18 crore
Market Cap Category	Large Cap

Zydus Lifesciences Ltd. (ZYDUSLIFE) rose to Rs 1,153.55 from the previous close of Rs 1,121, a move of Rs 32.55 or 2.9%. The stock opened at Rs 1,110.55, reached a high of Rs 1,162.5, recorded a low of Rs 1,110.55.

Zydus Lifesciences Share Price today rose Rs 32.55 from the previous close and was last traded at Rs 1,153.55. The stock opened near the lower end of the day’s band at Rs 1,110.55 and later touched Rs 1,162.50, which suggests that buyers absorbed early trading and kept the counter in positive territory. For Zydus Lifesciences Share Price Live monitoring, the important takeaway is simple: the market has repriced the stock higher today, but the verified data does not assign a company-specific reason. That makes the move relevant as a price-rise event rather than a story with an identified trigger. In Zydus Lifesciences Share Price news, such action often attracts interest because it can draw attention to the stock’s current valuation and sector standing.

Zydus Lifesciences Ltd. (ZYDUSLIFE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,11,820.18 crore
P/E Ratio	24.78x
P/B Ratio	4.15x
ROE	19.69%
ROCE	21.39%
EPS	Rs 45.24
Book Value Per Share	Rs 270.31
Dividend Yield	0.09%

Zydus Lifesciences Ltd. (ZYDUSLIFE) fundamental metrics show P/E 24.78x, P/B 4.15x, ROE 19.69%, ROCE 21.39%. These figures provide context only and are not a buy or sell signal.

Zydus Lifesciences Ltd. has a market capitalisation of Rs 111820.18 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.78x, P/B at 4.15x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.69% and ROCE of 21.39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 45.24, book value per share of Rs 270.31, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	24.78x
Benchmark Median P/E	32.83x
Benchmark Average P/E	48.79x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	4.15x
Benchmark Median P/B	2.92x
Company ROE	19.69%
Benchmark Median ROE	11.78%
Company ROCE	21.39%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 1,11,820.18 crore
Benchmark Median Market Cap	Rs 674.09 crore

Zydus Lifesciences Ltd. (ZYDUSLIFE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 24.78x, which is below the benchmark median of 32.83x, a difference of -24.52%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROE of 19.69%, which is above the benchmark median of 11.78%, a difference of +67.15%. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROCE of 21.39%, which is above the benchmark median of 13.65%, a difference of +56.7%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.67	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,41,576.41	82.59	13.68	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.58	20.55	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.19	3.18	11.83	16
Laurus Labs Ltd.	LAURUSLABS	99,417.45	90.93	17.63	18.31	18.2

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 24.78x compared with the displayed peer median of 82.59x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.39% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a market capitalisation of Rs 1,11,820.18 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Zydus Lifesciences

• Zydus Lifesciences Share Price rose 2.90% today, making it a visible mover in Stocks Rising Today.
• The stock traded between Rs 1,110.55 and Rs 1,162.50, which keeps Price Action in focus.
• Its P/E of 24.78 is below the industry median, adding context to Zydus Lifesciences Fundamental Analysis.
• ROE of 19.69% and ROCE of 21.39% compare well with the same-industry benchmark.
• Large market capitalisation and Healthcare sector positioning keep Zydus Lifesciences Stock News relevant for Market Movers.

About Zydus Lifesciences

Zydus Lifesciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of the listed Indian Stock Market universe and is tracked on NSE and BSE under the symbol ZYDUSLIFE. Its business profile fits a large pharmaceutical platform with a market capitalisation of Rs 1,11,820.18 crore, which places it among the major names that investors typically monitor for stock price updates, financial analysis and sector comparison.

From a business perspective, the company’s current metrics show a mix of scale and profitability. Revenue figures are not part of this update, so the reading here stays anchored to valuation, returns and market size. That makes Zydus Lifesciences Share Price useful for investors who follow stock market leaders in Healthcare, especially when comparing it with peers such as Cipla, Lupin, Sun Pharma and Divi's Laboratories. Univest tracks Zydus Lifesciences Stock News as part of its broader company coverage.

Frequently Asked Questions

Why is Zydus Lifesciences Share Price rising today?

Ans. Zydus Lifesciences Share Price rose 2.90% to Rs 1,153.55 in today’s market update. The latest Univest figures confirm the move, but they do not establish a company-specific catalyst.

What is Zydus Lifesciences Share Price Today?

Ans. Zydus Lifesciences Share Price Today is Rs 1,153.55, compared with the previous close of Rs 1,121.00. The stock is trading higher after gaining Rs 32.55 in the latest session so far.

How much did Zydus Lifesciences stock rise today?

Ans. Zydus Lifesciences stock rose 2.90% today. The move took the share price from the previous close of Rs 1,121.00 to Rs 1,153.55, keeping it in focus among Healthcare names.

What is Zydus Lifesciences market capitalisation?

Is Zydus Lifesciences expensive compared with peers?

Ans. Zydus Lifesciences Share Price trades at a P/E of 24.78, below the industry median of 32.83 and below several peers. Its valuation looks moderate rather than stretched on earnings.

How does Zydus Lifesciences compare on return ratios?

Ans. Zydus Lifesciences reports ROE of 19.69% and ROCE of 21.39%. Both are above the industry medians, which supports the stock’s fundamental profile versus the same-industry benchmark. The relevant peer median ROE is 11.78%.

What do EPS and book value show for Zydus Lifesciences?

Ans. EPS is 45.24 and book value is 270.31. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share at the current time.

Which peers are relevant for Zydus Lifesciences Share Price analysis?

Ans. Relevant peers include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Cipla and Lupin. Their P/E, ROE, ROCE and market cap figures help place Zydus Lifesciences Share Price in context.

Track Zydus Lifesciences Share Price on Univest

Use Zydus Lifesciences Ltd. (ZYDUSLIFE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track Zydus Lifesciences Share Price on Univest for live price updates, market cap, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value, dividend yield, sector comparison and peer context. Univest also helps users monitor Zydus Lifesciences Share Price Today alongside broader stock market updates and company news.